Schizophrenia Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Schizophrenia stocks.

Schizophrenia Stocks Recent News

Date Stock Title
Jul 19 LLY Palantir, Netflix, Domino's Pizza, Eli Lilly, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Jul 18 LLY Dow Jones Futures: Netflix Subscribers Jump As Tesla, Nvidia Resilient; President Biden Near Exiting Race?
Jul 18 LLY Healthcare stocks at an 'inflection point,' analyst says
Jul 18 LLY Jobless claims, healthcare, small caps: Trading Takeaways
Jul 18 LLY Eli Lilly, Novo Nordisk Shares Fall as Weight-Loss Drug Competition Ramps Up
Jul 18 LLY Eli Lilly, Novo extend muti-day decline in rare selloff
Jul 18 LLY Top Stock Movers Now: Domino's Pizza, Eli Lilly, DR Horton, and More
Jul 18 LLY The 5 Most Important Stocks to Watch During Q2 Earnings Season
Jul 18 LLY Novo Nordisk, Lilly Slide on Roche's Obesity Drug Study Data
Jul 18 ACAD Clinical Data from Open-Label Extension LILAC-1™ and LILAC-2™ Studies Evaluating Long-Term Safety and Efficacy of DAYBUE™ (trofinetide) in Patients with Rett Syndrome Published in Med
Jul 18 NBIX Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules to Ease Administration for Patients Experiencing Dysphagia or Difficulty Swallowing
Jul 18 LLY Will Eli Lilly Do a Stock Split in 2024?
Jul 18 LLY Amazon, Apple, Eli Lilly: Here's Morgan Stanley's earnings playbook
Jul 17 LLY China chip exports, Fed rate cut optimism: Market Domination
Jul 17 LLY Novo Nordisk, Eli Lilly fall on data from Roche's weight-loss pill
Jul 17 LLY Why Roche Stock Just Popped, but Eli Lilly and Novo Nordisk Dropped
Jul 17 LLY Roche Obesity Pill Achieves Positive Results in Early-Stage Trial
Jul 17 LLY FDA Accepts Lexicon's (LXRX) NDA for Type I Diabetes Drug
Jul 17 LLY Pfizer And Roche Advance On Their Weight Loss Drug Journeys
Jul 17 LLY Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?

Schizophrenia is a mental disorder characterized by abnormal behavior, strange speech and a decreased ability to understand reality. Other symptoms include false beliefs, unclear or confused thinking, hearing voices that do not exist, reduced social engagement and emotional expression and lack of motivation. People with schizophrenia often have additional mental health problems such as anxiety, depressive or substance-use disorders. Symptoms typically come on gradually, begin in young adulthood and in many cases never resolve.The causes of schizophrenia include environmental and genetic factors. Possible environmental factors include being raised in a city, cannabis use during adolescence, certain infections, the age of a person's parents, and poor nutrition during pregnancy. Genetic factors include a variety of common and rare genetic variants. Diagnosis is based on observed behavior, the person's reported experiences and reports of others familiar with the person. During diagnosis, a person's culture must also be taken into account. As of 2013, there is no objective test. Schizophrenia does not imply a "split personality" or dissociative identity disorder, conditions with which it is often confused in public perception.The mainstay of treatment is antipsychotic medication, along with counselling, job training and social rehabilitation. It is unclear whether typical or atypical antipsychotics are better. In those who do not improve with other antipsychotics, clozapine may be tried. In more serious situations where there is risk to self or others, involuntary hospitalization may be necessary, although hospital stays are now shorter and less frequent than they once were.About 0.3% to 0.7% of people are affected by schizophrenia during their lifetimes. In 2013, there were an estimated 23.6 million cases globally. Males are more often affected and on average experience more severe symptoms. About 20% of people eventually do well, and a few recover completely; about 50% have lifelong impairment. Social problems, such as long-term unemployment, poverty and homelessness, are common. The average life expectancy of people with the disorder is 10–25 years less than that of the general population. This is the result of increased physical health problems and a higher suicide rate (about 5%). In 2015, an estimated 17,000 people worldwide died from behavior related to, or caused by, schizophrenia.

Browse All Tags